(Press-News.org) A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings suggest further development of this approach is merited.
In the study, published Jan. 12 in Communications Medicine, the researchers performed whole-genome sequencing analysis on hundreds of tumor samples obtained by informed consent as part of a precision medicine initiative by Weill Cornell, NewYork-Presbyterian and Illumina, Inc., a biotechnology company known for its DNA sequencing technology. They used the results to train and validate an algorithm that detects homologous recombination deficiency, a type of DNA-repair defect. Tumors with this defect are vulnerable to PARP inhibitors, which further disrupt DNA repair, causing cancer cells to accumulate DNA damage and die. Platinum-based chemotherapies, which also damage DNA, tend to work better in these cases. An initial test suggested that the algorithm is more accurate in predicting PARP-inhibitor treatment responses compared with existing methods.
“A comprehensive analysis of the entire genome has advantages compared with traditional, targeted detection strategies for predicting homologous recombination deficiency,” said study senior author Dr. Juan Miguel Mosquera, professor of pathology and laboratory medicine and director of research pathology at the Englander Institute for Precision Medicine at Weill Cornell and a pathologist at NewYork-Presbyterian/Weill Cornell Medical Center. Dr. Mosquera is also a member of the Sandra and Edward Meyer Cancer Center at Weill Cornell.
The study was a collaboration with the medical diagnostics company Isabl, Inc.
Until now, clinicians have focused primarily on BRCA1 and BRCA2 mutations, the most frequent drivers of this DNA-repair defect, to determine if patients will benefit from PARP inhibitors. These mutations can be found most frequently in patients with breast, ovarian, pancreatic and prostate cancers. However, research shows that many other gene mutations can also disrupt this repair process—and in recent years, whole-genome sequencing, which can detect these broader changes, has become affordable enough for routine use.
The team used 305 samples from Weill Cornell and NewYork-Presbyterian patients with various cancers to train an algorithm that was developed by Isabl. The algorithm looks for a genome-wide variety of DNA defects that are known to be associated with homologous recombination repair deficiency. They then validated the algorithm using a cohort of 556 cancers and tested it against commercial methods using an additional 212 tumor samples.
The algorithm detected the DNA-repair deficiency in many of the samples, including 21% of breast tumors, 20% of pancreatic and bile duct tumors, and 17% of gynecological tumors. Notably, 24% of the detected cases did not involve BRCA1 or BRCA2 mutations, highlighting the diversity of the underlying genetic mutations.
In several cases, the algorithm appeared to flag “false negative” and “false positive” predictions from the commercial method that didn’t match patient outcomes.
The team plans to conduct larger studies of the new detection algorithm as a general tool to guide cancer treatment.
END
Whole-genome sequencing may optimize PARP inhibitor use
2026-01-12
ELSE PRESS RELEASES FROM THIS DATE:
Like alcohol units, but for cannabis – experts define safer limits
2026-01-12
Researchers at the University of Bath in the UK are proposing thresholds for safe – or at least safer – cannabis use and hope their findings will help people monitor consumption and keep it within recommended limits – similar to how alcohol units guide safer drinking.
The threshold recommendations, proposed in a paper published today in the journal Addiction, are based on a system for measuring cannabis consumption not by weight but by THC content (THC is the compound responsible for the psychoactive effects of cannabis).
In the same ...
DNA testing of colorectal polyps improves insight into hereditary risks
2026-01-12
In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients. Research from Radboud university medical center and university hospital Bonn (UKB) in collaboration with researchers from Munich and Barcelona, shows that DNA analysis of colorectal polyps provides important additional information on the development of these polyps and colorectal cancer. This DNA analysis leads to better diagnostics and treatment ...
Researchers uncover axonal protein synthesis defect in ALS
2026-01-12
Leuven, January 12, 2026 – Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS). The study, published in Nature Neuroscience, reveals an early weakness in neurodegeneration and highlights a potential target for future therapies.
Building proteins
Motor neurons depend on local protein production within their axons to support their long-distance connections to muscles. Using advanced spatial transcriptomics, scientists at the VIB–KU Leuven Center for Brain & Disease Research analyzed gene expression ...
Why are men more likely to develop multiple myeloma than women?
2026-01-12
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as high in men than in women. A new study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, provides insights that may help to explain this disparity.
To investigate the sex difference in MM, researchers analyzed data on 850 patients with newly diagnosed MM enrolled in the Integrative Molecular And Genetic Epidemiology (IMAGE) study at the University of Alabama at Birmingham.
Compared with female patients, male patients were more likely to have advanced (International Staging System stage III) disease at the time of diagnosis. Males ...
Smartphone-based interventions show promise for reducing alcohol and cannabis use: New research
2026-01-12
by W.B. Kagan
PISCATAWAY, NJ – Young adults today are digital natives—naturally fluent with devices and online platforms—so some of their most effective behavioral-health interventions will likely arrive in their pockets via text, app, or other mobile medium. Now, new research shows that such interventions for alcohol and cannabis use among young adults show potential to reduce harms, according to three reports in the Journal of Studies on Alcohol and Drugs.
Heavy drinking and cannabis use among young adults continue to exact a great cost from individuals and society, ...
How do health care professionals determine eligibility for MAiD?
2026-01-12
How do health care professionals in Canada assess applicants for medical assistance in dying (MAiD)? A research article in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251071 describes the careful approach currently used to determine eligibility, and an analysis article suggests an approach to eligibility assessments for advance requests for MAiD — which are currently available in Quebec and being considered elsewhere in Canada.
In 2021, Canada ...
Microplastics detected in rural woodland
2026-01-12
Air-polluting microplastics have been found in rural environments in greater quantities than in urban locations, researchers say.
Scientists led by the University of Leeds detected up to 500 microscopic particles of plastic per square metre per day in an area of woodland during the three-month study – almost twice as much as in a sample collected in a city centre.
They believe trees and other vegetation capture airborne microplastic particles from the atmosphere and deposit them, highlighting the impact ...
JULAC and Taylor & Francis sign open access agreement to boost the impact of Hong Kong research
2026-01-12
Researchers in Hong Kong will have greater opportunities to share their work with a global audience through a new open access (OA) agreement between the Joint University Librarians Advisory Committee (JULAC) and Taylor & Francis.
The three-year agreement enables researchers at all participating institutions to publish OA articles in over 2,000 Taylor & Francis and Routledge Open Select (hybrid) journals without payment of an OA article publishing charge. Articles will be open on publication and free to access and reuse for readers around the world, ...
Protecting older male athletes’ heart health
2026-01-12
Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while exercising, new University of Leeds research shows.
Published today and funded by the British Heart Foundation, the study shows that male endurance athletes aged over 50 may be more likely to experience abnormal heart rhythms during training if they already have scarring in their heart.
Nine in 10 sudden cardiac deaths during sport occur in older male athletes.
The researchers’ aim ...
KAIST proposes AI-driven strategy to solve long-standing mystery of gene function
2026-01-11
“We know the genes, but not their functions.” To resolve this long-standing bottleneck in microbial research, a joint research team has proposed a cutting-edge research strategy that leverages Artificial Intelligence (AI) to drastically accelerate the discovery of microbial gene functions.
KAIST announced on January 12th that a research team led by Distinguished Professor Sang Yup Lee from the Department of Chemical and Biomolecular Engineering, in collaboration with Professor Bernhard Palsson from the Department of Bioengineering at UCSD, has published a comprehensive review paper. The study systematically analyzes and organizes the latest AI-based ...